Azenta Inc (NAS:AZTA)
$ 46.21 -0.9 (-1.91%) Market Cap: 2.11 Bil Enterprise Value: 1.74 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 72/100

Azenta Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 08:45PM GMT
Release Date Price: $93.88 (-0.33%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

All right. Hi, everyone. My name is Casey Woodring from the Life Science Tools team here at JPMorgan. Welcome to our Annual Healthcare Conference. I'm pleased to introduce our next company, Azenta.

Just a quick reminder before I hand it off to the management team. If you would like to ask a question during the Q&A portion of the presentation, there's an opportunity to do so on the website. So with that, I'll turn it over to Steve. Thanks.

Stephen S. Schwartz
Azenta, Inc. - CEO, President & Director

Casey, thanks very much, and thanks for the invitation. We're really delighted to be here at the JPMorgan Healthcare Conference and especially for a chance to introduce you to Azenta Life Sciences. But before I begin, and before Lindon and I share the presentation here, I want to call your attention to the safe harbor statement as we will be making forward-looking statements, and we call your attention to more fulsome description at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot